Association between genetic polymorphism and adverse events or effectiveness of S-1-based chemotherapy in patients with gastrointestinal cancer.
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2012
At a glance
- Drugs Antineoplastics; Gimeracil/oteracil/tegafur
- Indications Biliary cancer; Colorectal cancer; Gastric cancer; Pancreatic cancer
- Focus Adverse reactions; Pharmacogenomic
- 01 Mar 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 18 Dec 2009 New trial record